The BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.
The measurement of these antibodies is claimed to have recently been cited as a key parameter in the definitive diagnosis of rheumatoid arthritis by the American College of Rheumatology.
The BioPlex 2200 system is an automated, random-access multiplex testing platform with an assay menu targeting autoimmune diagnostics and infectious diseases. The anti-CCP kit is pending clearance by the US FDA.
Phone: 0011 1 510 724 7000
Amsbio Acepix FFPE tissue blocks
Amsbio has expanded its range of high-quality formalin-fixed, paraffin-embedded (FFPE) tissues...
Promega Paradyme 27GY STR System
The Paradyme 27GY STR System features a novel enzyme that reduces the most common type of...
Mercodia Insulin MBeads Assay
The assay is designed to offer high accuracy by specifically measuring human insulin while...
